Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter

Journal of Medical Virology

Volumn 79, Issue 10, 2007, Pages 1527-1536

  Jääskeläinen, Kirsi M ^a   Kaukinen, Pasi ^a,d   Minskaya, Ekaterina S ^b,e   Plyusnina, Angelina ^a   Vapalahti, Olli ^a   Elliott, Richard M ^b,f   Weber, Friedemann ^c   Vaheri, Antti ^a   Plyusnin, Alexander ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Hantavirus; IFN; Innate immunity; NSs ORF; PUUV; TULV

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENOME; HANTAVIRUS; IN VITRO STUDY; NONHUMAN; PUUMALA VIRUS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DOWN-REGULATION; HANTAVIRUS; HANTAVIRUS INFECTIONS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NUCLEOCAPSID PROTEINS; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); PUUMALA VIRUS; SEQUENCE ALIGNMENT; VIRAL NONSTRUCTURAL PROTEINS;

ARVICOLINAE; HANTAVIRUS; PUUMALA; PUUMALA VIRUS; RODENTIA; SIGMODONTINAE; TULA VIRUS;

EID: 34548245061     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20948     Document Type: Article

References (50)

1. Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, Geimonen E, Sen N, Reich NC, Mackow ER. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80:9676-9686.
2. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798-9806.
3. Blakqori G, Weber F. 2005. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol 79:10420-10428.
4. Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O. 2001. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75:1371-1377.
5. Bowen MD, Kariwa H, Rollin PE, Peters CJ, Nichol ST. 1995. Genetic characterization of a human isolate of Puumala hantavirus from France. Virus Res 38:279-289.
6. Bridgen A, Weber F, Fazakerley JK, Elliott RM. 2001. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA 98:664-669.
7. Cantell K, Hirvonen S, Kauppinen HL, Kalkkinen N. 1991. Rapid production of interferon-gamma in uninduced human leukocyte suspensions. J Interferon Res 11:231-236.
8. Collins SE, Noyce RS, Mossman KL. 2004. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78:1706-1717.
9. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD. 1988. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85:5259-5263.
10. Fuerst TR, Niles EG, Studier FW, Moss B. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
11. García-Sastre A. 2004. Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. Curr Top Microbiol Immunol 283:249-280.
12. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 99:13837-13842.
13. Haller O, Kochs G. 2002. Interferon-induced mx proteins: Dynamin-like GTPases with antiviral activity. Traffic 3:710-717.
14. Haller O, Kochs G, Weber F. 2006. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 344:119-130.
15. Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, Makela MJ. 1997. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res 41:647-650.
16. Kaukinen P, Vaheri A, Plyusnin A. 2005. Hantavirus nucleocapsid protein: A multifunctional molecule with both housekeeping and ambassadorial duties. Arch Virol 150:1693-1713.
17. Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC. 2005. Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. J Med Virol 75:267-275.
18. Kimura M. 1983. The theory of molecular evolution. Cambridge: Cambridge University Press.
19. King MC, Raposo G, Lemmon MA. 2004. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl Acad Sci USA 101:8957-8962.
20. Kohl A, Clayton RF, Weber F, Bridgen A, Randall RE, Elliott RM. 2003. Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol 77:7999-8008.
21. Kozak M. 1984. Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature 308:241-246.
22. Kozak M. 1990. Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes. Proc Natl Acad Sci USA 87:8301-8305.
23. Kozak M. 1991. An analysis of vertebrate mRNA sequences: Intimations of translational control. J Cell Biol 115:887-903.
24. Kraus AA, Raftery MJ, Giese T, Ulrich R, Zawatzky R, Hippenstiel S, Suttorp N, Krüger DH, Schönrich G. 2004. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 78:6143-6150.
25. Kukkonen SK, Vaheri A, Plyusnin A. 2004. Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein. J Gen Virol 85:1181-1189.
26. Le May N, Dubaele S, De Santis LP, Billecocq A, Bouloy M, Egly JM. 2004. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541-550.
27. Li XD, Kukkonen S, Vapalahti O, Plyusnin A, Lankinen H, Vaheri A. 2004. Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol 85:3261-3268.
28. Mensink E, van de Locht A, Schattenberg A, Linders E, Schaap N, Geurts van Kessel A, De Witte T. 1998. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol 102:768-774.
29. Nichol ST, Beaty BJ, Elliott RM, Goldbach R, Plyusnin A, Schmaljohn CS, Tesh RB. 2005. Bunyaviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus taxonomy. VIIIth Report of the International Committee on Taxonomy of Viruses. Amsterdam: Elsevier Academic Press. pp 695-716.
30. Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J. 1992. Hantaan virus infection of human endothelial cells. J Virol 66:5929-5936.
31. Plyusnin A, Cheng Y, Vapalahti O, Pejcoch M, Unar J, Jelinkova Z, Lehväslaiho H, Lundkvist Å, Vaheri A. 1995. Genetic variation in Tula hantaviruses: Sequence analysis of the S and M segments of strains from Central Europe. Virus Res 39:237-250.
32. Plyusnin A, Morzunov SP. 2001. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol 256:47-75.
33. Plyusnin A, Vapalahti O, Lankinen H, Lehväslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist A, Brummer-Korvenkontio M, Gavrilovskaya I, Vaheri A. 1994. Tula virus: A newly detected hantavirus carried by European common voles. J Virol 68:7833-7839.
34. Plyusnin A. 2002. Genetics of hantaviruses: Implications to taxonomy. Arch Virol 147:665-682.
35. Prescott J, Ye C, Sen G, Hjelle B. 2005. Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol 79:15007-15015.
36. Schmaljohn CS, Hooper JW. 2001. Bunyaviridae: The viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology 4th edition, Vol. 2. Philadelphia: Lippincott Williams & Wilkins. pp 1581-1602.
37. Spiegel M, Pichlmair A, Martinez-Sobrido L, Cros J, García-Sastre A, Haller O, Weber F. 2005. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79:2079-2086.
38. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE. 2007. Andes and prospect hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81:2769-2776.
39. Takeda A, Sugiyama K, Nagano H, Mori M, Kaido M, Mise K, Tsuda S, Okuno T. 2002. Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus. FEBS Lett 532:75-79.
40. Tamura M, Asada H, Kondo K, Takahashi M, Yamanishi K. 1987. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res 8:171-178.
41. Temonen M, Lankinen H, Vapalahti O, Ronni T, Julkunen I, Vaheri A. 1995. Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages. Virology 206:8-15.
42. Thomas D, Blakqori G, Wagner V, Banholzer M, Kessler N, Elliott RM, Haller O, Weber F. 2004. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279:31471-31477.
43. Vapalahti O, Kallio-Kokko H, Salonen EM, Brummer-Korvenkontio M, Vaheri A. 1992. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: Evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol 73:829-838.
44. Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist Å, Plyusnin A, Lehväslaiho H, Brummer-Korvenkontio M, Vaheri A, Lankinen H. 1995. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol 46:293-303.
45. Vapalahti O, Lundkvist Å, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 77:3063-3067.
46. Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949-7955.
47. Weber F, Kochs G, Haller O. 2004. Inverse interference: How viruses fight the interferon system. Viral Immunol 17:498-515.
48. Weber F, Wagner V, Kessler N, Haller O. 2006. Induction of interferon synthesis by the PKR-inhibitory VA RNAs of adenoviruses. J Interferon Cytokine Res 26:1-7.
49. Yoneyama M, Suhara W, Fukuhara Y, Sato M, Ozato K, Fujita T. 1996. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J Biochem 120:160-169.
50. Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, Collins PL, Elliott RM, Randall RE. 2003. Virus replication in engineered human cells that do not respond to interferons. J Virol 77:2174-2181.